REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jadefarma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jadefarma S.A. Profile Updated: March 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Jadefarma S.A. is based in Ecuador. The head office is in Rocafuerte. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on August 26, 2020. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Jadefarma S.A. reported a net sales revenue increase of 40.65% in 2025. Its’ total assets recorded a negative growth of 49.32%. Jadefarma S.A.’s net profit margin decreased by 0.67% in 2025.

Headquarters
Calle 13 Marzo
Rocafuerte; Manabi;

Contact Details: Purchase the Jadefarma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Jadefarma S.A. report to view the information.
Registered Capital:
Purchase the Jadefarma S.A. report to view the information.
Financial Auditors:
Purchase the Jadefarma S.A. report to view the information.
Incorporation Date:
August 26, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Jadefarma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
40.65%▲
Total Operating Revenue
40.65%▲
Operating Profit
-27.93%▼
EBITDA
-27.93%▼
Net Profit/Loss for the Period
-27.93%▼
Total Assets
-49.32%▼
Total Equity
-13.16%▼
Operating Profit Margin
-0.67%▼
Net Profit Margin
-0.67%▼
Return on Equity (ROE)
-8.02%▼
Quick Ratio
-0.35%▼
Cash Ratio
-0.35%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo